NASDAQ:TRPX - THERAPIX BIOSCI/S Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$8.65 +0.22 (+2.61 %)
(As of 11/19/2018 02:32 AM ET)
Previous Close$8.65
Today's Range$8.13 - $8.9325
52-Week Range$3.00 - $9.30
Volume121,782 shs
Average Volume373,762 shs
Market Capitalization$30.25 million
P/E Ratio11.23
Dividend YieldN/A
Beta-1.9
Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include THX-110 for the treatment of Tourette syndrome, Obstructive Sleep Apnea, and pain; THX-130 for the treatment of Mild Cognitive Impairment and Traumatic Brain Injury; THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain. Therapix Biosciences Ltd. has a product development agreement with Cure Pharmaceutical to develop cannabinoid-based product for sleep disorders. The company was formerly known as NasVax Ltd. and changed its name to Therapix Biosciences Ltd. in November 2013. Therapix Biosciences Ltd. was founded in 2004 and is headquartered in Givatayim, Israel.

Receive TRPX News and Ratings via Email

Sign-up to receive the latest news and ratings for TRPX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TRPX
Previous Symbol
CUSIPN/A
Phone972-3616-7055

Debt

Debt-to-Equity RatioN/A
Current Ratio5.10
Quick Ratio5.10

Price-To-Earnings

Trailing P/E Ratio11.23
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash Flow$1.8058 per share
Price / Cash4.79
Book Value$2.42 per share
Price / Book3.57

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-6,240,000.00
Net MarginsN/A
Return on Equity33.18%
Return on Assets28.76%

Miscellaneous

Employees12
Outstanding Shares3,500,000
Market Cap$30.25 million
OptionableNot Optionable

THERAPIX BIOSCI/S (NASDAQ:TRPX) Frequently Asked Questions

What is THERAPIX BIOSCI/S's stock symbol?

THERAPIX BIOSCI/S trades on the NASDAQ under the ticker symbol "TRPX."

How were THERAPIX BIOSCI/S's earnings last quarter?

THERAPIX BIOSCI/S (NASDAQ:TRPX) posted its earnings results on Monday, August, 20th. The company reported ($0.35) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.59) by $0.24. View THERAPIX BIOSCI/S's Earnings History.

When is THERAPIX BIOSCI/S's next earnings date?

THERAPIX BIOSCI/S is scheduled to release their next quarterly earnings announcement on Thursday, November 22nd 2018. View Earnings Estimates for THERAPIX BIOSCI/S.

Has THERAPIX BIOSCI/S been receiving favorable news coverage?

Headlines about TRPX stock have been trending positive recently, according to InfoTrie Sentiment. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. THERAPIX BIOSCI/S earned a media sentiment score of 2.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next several days.

Who are some of THERAPIX BIOSCI/S's key competitors?

Who are THERAPIX BIOSCI/S's key executives?

THERAPIX BIOSCI/S's management team includes the folowing people:
  • Dr. Ascher Shmulewitz, Chairman & Interim CEO (Age 62)
  • Dr. Adi Zuloff-Shani, Chief Technology Officer (Age 50)
  • Mr. Oz Adler CPA, Chief Financial Officer (Age 32)

How do I buy shares of THERAPIX BIOSCI/S?

Shares of TRPX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is THERAPIX BIOSCI/S's stock price today?

One share of TRPX stock can currently be purchased for approximately $8.65.

How big of a company is THERAPIX BIOSCI/S?

THERAPIX BIOSCI/S has a market capitalization of $30.25 million. THERAPIX BIOSCI/S employs 12 workers across the globe.

What is THERAPIX BIOSCI/S's official website?

The official website for THERAPIX BIOSCI/S is http://www.therapixbio.com.

How can I contact THERAPIX BIOSCI/S?

THERAPIX BIOSCI/S's mailing address is 4 Ariel Sharon StreetHaShahar Tower 16th Floor, Givatayim L3, 5320047. The company can be reached via phone at 972-3616-7055.


MarketBeat Community Rating for THERAPIX BIOSCI/S (NASDAQ TRPX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  164 (Vote Outperform)
Underperform Votes:  165 (Vote Underperform)
Total Votes:  329
MarketBeat's community ratings are surveys of what our community members think about THERAPIX BIOSCI/S and other stocks. Vote "Outperform" if you believe TRPX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRPX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel